Cognition Therapeutics Q3 EPS $(0.06) Beats $(0.09) Estimate
Benzinga Newsdesk 12 months ago
EarningsEarnings BeatsNews
Cognition Therapeutics (NASDAQ:CGTX) reported quarterly losses of $(0.06) per share which beat the analyst consensus estimate of $(0.09) by 33.33 percent. This is a 76 percent increase over losses of $(0.25) per share
Cognition Therapeutics (NASDAQ:CGTX) reported quarterly losses of $(0.06) per share which beat the analyst consensus estimate of $(0.09) by 33.33 percent. This is a 76 percent increase over losses of $(0.25) per share from the same period last year.